The foundation for this joint initiative is Phyton Biotech’s proprietary Plant Cell Fermentation (PCF®) technology, a unique platform that enables renewable, reliable and scalable supply of ...

As a national leader in oncology advancement and as the largest integrated healthcare system in the nation, the Department of Veterans Affairs (VA) has announced an important and substantial ...

FORT WORTH, Texas--(BUSINESS WIRE)--Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) ...

VANCOUVER, BC--(Marketwired - October 07, 2014) - Phyton Biotech, the pioneer in plant cell fermentation (PCF®) technology with the world's largest capacity for paclitaxel and docetaxel API via PCF, ...

Birkerød, Denmark December 14 2011, NKT Photonics, announces that it has licensed parts of its unique Photonic Crystal Fiber technology to GLOphotonics. The technology was originally developed by ...

Phyton Biotech and PellePharm today announced an exclusive partnership to develop a plant cell culture-based process to enable the future renewable production of the raw material for PellePharm's ...

FORT WORTH, Texas — Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, are pleased ...